Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
homeobox D13 | 0.483 | 0.808 | 8.6E-03 |
|
group | 0.090 | None | 1.000 | 8 | 0 | 2000 | 2018 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
group | 0.080 | None | 1.000 | 8 | 0 | 2001 | 2018 | ||||||||
|
Wnt family member 1 | 0.495 | 0.769 | 0.33 |
|
group | 0.080 | None | 1.000 | 8 | 0 | 2008 | 2018 | ||||||||
|
zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2 | 0.751 | 0.231 | 1.00 |
|
group | 0.580 | None | 1.000 | 8 | 0 | 2012 | 2020 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.370 | None | 1.000 | 7 | 0 | 1988 | 2017 | ||||||||
|
phospholipase C beta 1 | 0.595 | 0.654 | 0.98 |
|
group | 0.380 | None | 0.875 | 7 | 0 | 2004 | 2018 | ||||||||
|
SET binding protein 1 | 0.503 | 0.808 | 1.00 |
|
group | 0.570 | None | 1.000 | 7 | 0 | 2013 | 2018 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
group | 0.370 | None | 1.000 | 7 | 0 | 1992 | 2019 | ||||||||
|
hematopoietic prostaglandin D synthase | 0.388 | 0.923 | 1.8E-06 |
|
group | 0.070 | None | 0.857 | 7 | 0 | 1998 | 2013 | ||||||||
|
phosphatidylinositol glycan anchor biosynthesis class A | 0.575 | 0.654 | 0.96 |
|
group | 0.170 | None | 1.000 | 7 | 0 | 1998 | 2017 | ||||||||
|
homeobox A9 | 0.521 | 0.692 | 4.4E-05 |
|
group | 0.070 | None | 1.000 | 7 | 0 | 1999 | 2013 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
group | 0.070 | None | 1.000 | 7 | 0 | 2008 | 2018 | ||||||||
|
BMI1 proto-oncogene, polycomb ring finger | 0.448 | 0.808 | 0.94 |
|
group | 0.370 | None | 1.000 | 7 | 0 | 2007 | 2014 | ||||||||
|
ribosomal protein S19 | 0.480 | 0.846 | 0.92 |
|
group | 0.160 | None | 1.000 | 6 | 0 | 2007 | 2019 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
group | 0.080 | None | 1.000 | 6 | 0 | 2001 | 2018 | ||||||||
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 1991 | 2017 | |||||||||
|
NLR family pyrin domain containing 3 | 0.361 | 0.962 | 8.1E-04 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 2016 | 2019 | ||||||||
|
delta like non-canonical Notch ligand 1 | 0.527 | 0.692 | 3.5E-02 |
|
group | 0.370 | None | 1.000 | 6 | 0 | 2001 | 2018 | ||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 2011 | 2018 | |||||||||
|
arylacetamide deacetylase | 0.631 | 0.615 | 2.9E-03 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 2005 | 2019 | ||||||||
|
solute carrier organic anion transporter family member 6A1 | 0.412 | 0.885 | 2.9E-11 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 1990 | 2015 | ||||||||
|
checkpoint kinase 2 | 0.460 | 0.808 | 1.2E-24 |
|
group | 0.060 | None | 0.833 | 6 | 0 | 2001 | 2018 | ||||||||
|
SLU7 homolog, splicing factor | 0.729 | 0.346 | 1.6E-09 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 2016 | 2019 | ||||||||
|
platelet activating factor acetylhydrolase 1b regulatory subunit 1 | 0.504 | 0.769 | 1.00 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 2017 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 1993 | 2019 |